Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled, Multicenter, Double-Masked, Parallel Phase III Trial to Evaluate the Efficacy and Safety of Lotilaner Ophthalmic Solution for the Treatment of Demodex Blepharitis in China With an Open-Label Pharmacokinetics Sub-Study

NCT05629390 is registered in ClinicalTrials.gov with LianBio LLC as lead sponsor.

NCT NCT05629390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05629390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled, Multicenter, Double-Masked, Parallel Phase III Trial to Evaluate the Efficacy and Safety of Lotilaner Ophthalmic Solution for the Treatment of Demodex Blepharitis in China With an Open-Label Pharmacokinetics Sub-Study
Lead sponsor
LianBio LLC
Phase
Phase 3
Overall status
Completed
Start date
October 23, 2022
Completion date
April 2, 2024
Enrollment
163 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

blepharitis